tiprankstipranks
Genetic Technologies (GNTLF)
OTHER OTC:GNTLF

Genetic Technologies (GNTLF) Stock Price & Analysis

1 Followers

GNTLF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.00 - $6.47
Previous Close$3.19
Volume0.00
Average Volume (3M)N/A
Market Cap
$12.23M
Enterprise Value$7.52M
Total Cash (Recent Filing)AU$7.87M
Total Debt (Recent Filing)AU$532.85K
Price to Earnings (P/E)-38.7
Beta-9.66
Aug 29, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding1
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation12.60
R-Squared0.02
Alpha4.58
Financial Highlights & Ratios
Price to Book (P/B)1.88
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

GNTLF FAQ

What was Genetic Technologies’s price range in the past 12 months?
Genetic Technologies lowest stock price was $0.00 and its highest was $6.47 in the past 12 months.
    What is Genetic Technologies’s market cap?
    Currently, no data Available
    When is Genetic Technologies’s upcoming earnings report date?
    Genetic Technologies’s upcoming earnings report date is Aug 29, 2024 which is in 128 days.
      How were Genetic Technologies’s earnings last quarter?
      Genetic Technologies released its earnings results on Feb 23, 2024. The company reported -$0.036 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.036.
        Is Genetic Technologies overvalued?
        According to Wall Street analysts Genetic Technologies’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Genetic Technologies pay dividends?
          Genetic Technologies does not currently pay dividends.
          What is Genetic Technologies’s EPS estimate?
          Genetic Technologies’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Genetic Technologies have?
          Currently, no data Available
          What happened to Genetic Technologies’s price movement after its last earnings report?
          Genetic Technologies reported an EPS of -$0.036 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
            Which hedge fund is a major shareholder of Genetic Technologies?
            Currently, no hedge funds are holding shares in GNTLF
            ---

            Genetic Technologies Stock Smart Score

            Company Description

            Genetic Technologies

            Genetic Technologies Ltd. engages in the provision of molecular risk assessment for cancer. It operates through the USA and Australia geographical segments. Its product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Moleculin Biotech
            Vericel
            ADMA Biologics
            Genetic Technologies
            Popular Stocks
            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis